{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T09:59:28Z","timestamp":1770458368383,"version":"3.49.0"},"reference-count":16,"publisher":"BMJ","issue":"10","license":[{"start":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T00:00:00Z","timestamp":1635465600000},"content-version":"unspecified","delay-in-days":28,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2021,9,17]]},"published-print":{"date-parts":[[2021,10]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Adenomyosis can adversely reduce chances of pregnancy in couples undergoing assisted conception. We aim to evaluate the effect of two different downregulation protocols on the reproductive outcomes in women with moderate and severe adenomyosis undergoing frozen-thawed embryo transfer (FTET).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>We will conduct a two-armed pragmatic randomised clinical trial comparing modified downregulation with gonadotrophin-releasing hormone (GnRH) analogue for 6 weeks to standard downregulation with GnRH analogue for 1 week prior to FTET. Our primary outcome is clinical pregnancy, defined as a viable intrauterine pregnancy confirmed by ultrasound at greater than 6 weeks gestation, with other secondary reproductive, neonatal and safety outcomes. We aim to randomise 162 patients over 3 years to achieve 80% power for detecting a 20% difference in the primary outcome at 5% significance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>To date there is no consensus on the optimal protocol for management of subfertile women with adenomyosis. Modified downregulation could improve the clinical pregnancy rate by reducing the endometrial inflammatory reaction and\/or myometrial contractility and their impact on uterine receptivity in women with moderate and severe adenomyosis of the uterus undergoing FTET. The MODA trial is designed to offer pragmatic, real-life evaluation of the optimal protocol for downregulation for this population during assisted conception treatments. Our findings will be published in peer-reviewed journals and presented at national and international scientific meetings and congresses. Ethical approval was granted by the NHS Research Ethics Committees (19\/LO\/1567).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT03946722\">NCT03946722<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2021-050248","type":"journal-article","created":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T12:05:20Z","timestamp":1635509120000},"page":"e050248","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":5,"title":["Effectiveness of modified downregulation for women with moderate and severe adenomyosis of the uterus prior to frozen thawed embryo transfer (MODA) study protocol: a pragmatic randomised-controlled trial"],"prefix":"10.1136","volume":"11","clinical-trial-number":[{"clinical-trial-number":"nct03946722","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2578-322X","authenticated-orcid":false,"given":"Sania","family":"Latif","sequence":"first","affiliation":[{"name":"Reproductive Medicine Unit, University College London Hospital, London, UK"},{"name":"UCL Institute for Women\"s Health, University College London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bassel H Al","family":"Wattar","sequence":"additional","affiliation":[{"name":"Reproductive Medicine Unit, University College London Hospital, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neerujah","family":"Balachandren","sequence":"additional","affiliation":[{"name":"Reproductive Medicine Unit, University College London Hospital, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomasz","family":"Lukaszewski","sequence":"additional","affiliation":[{"name":"Reproductive Medicine Unit, University College London Hospital, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ertan","family":"Saridogan","sequence":"additional","affiliation":[{"name":"Reproductive Medicine Unit, University College London Hospital, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ephia","family":"Yasmin","sequence":"additional","affiliation":[{"name":"Reproductive Medicine Unit, University College London Hospital, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Serhal","sequence":"additional","affiliation":[{"name":"Centre for Reproductive and Genetic Health, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4106-8514","authenticated-orcid":false,"given":"Dimitrios","family":"Mavrelos","sequence":"additional","affiliation":[{"name":"Reproductive Medicine Unit, University College London Hospital, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2021,10,29]]},"reference":[{"key":"2025121409055075000_11.10.e050248.1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(72)90781-8"},{"key":"2025121409055075000_11.10.e050248.2","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/des332"},{"key":"2025121409055075000_11.10.e050248.3","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deu041"},{"key":"2025121409055075000_11.10.e050248.4","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.fertnstert.2017.06.025","article-title":"Effects of adenomyosis on in vitro fertilization treatment outcomes: a meta-analysis","volume":"108","author":"Younes","year":"2017","journal-title":"Fertil Steril"},{"key":"2025121409055075000_11.10.e050248.5","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.rbmo.2017.06.026","article-title":"The impact of adenomyosis on the outcome of IVF-embryo transfer","volume":"35","author":"Mavrelos","year":"2017","journal-title":"Reprod Biomed Online"},{"key":"2025121409055075000_11.10.e050248.6","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.rbmo.2017.06.016","article-title":"Pathogenesis of adenomyosis: an update on molecular mechanisms","volume":"35","author":"Vannuccini","year":"2017","journal-title":"Reprod Biomed Online"},{"key":"2025121409055075000_11.10.e050248.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2009.01.097"},{"key":"2025121409055075000_11.10.e050248.8","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deq240"},{"key":"2025121409055075000_11.10.e050248.9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1479-828X.2010.01276.x"},{"key":"2025121409055075000_11.10.e050248.10","doi-asserted-by":"publisher","DOI":"10.3109\/09513590.2013.824960"},{"key":"2025121409055075000_11.10.e050248.11","doi-asserted-by":"crossref","first-page":"169","DOI":"10.5653\/cerm.2016.43.3.169","article-title":"Pregnancy rate in women with adenomyosis undergoing fresh or frozen embryo transfer cycles following gonadotropin-releasing hormone agonist treatment","volume":"43","author":"Park","year":"2016","journal-title":"Clin Exp Reprod Med"},{"key":"2025121409055075000_11.10.e050248.12","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.rbmo.2020.07.027","article-title":"The impact of adenomyosis on IVF in infertile women with normal ovarian reserve following long or ultra-long GnRH-agonist treatment","volume":"41","author":"Hou","year":"2020","journal-title":"Reprod Biomed"},{"key":"2025121409055075000_11.10.e050248.13","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.00318","article-title":"Impact of gonadotropin-releasing hormone agonist pre-treatment on the cumulative live birth rate in infertile women with adenomyosis treated with IVF\/ICSI: a retrospective cohort study","volume":"11","author":"Chen","year":"2020","journal-title":"Front Endocrinol"},{"key":"2025121409055075000_11.10.e050248.14","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.609771","article-title":"Ultra-Long GnRH agonist protocol during IVF\/ICSI improves pregnancy outcomes in women with adenomyosis: a retrospective cohort study","volume":"12","author":"Lan","year":"2021","journal-title":"Front Endocrinol"},{"key":"2025121409055075000_11.10.e050248.15","unstructured":"National Institute for Health and Care Excellence (NICE) . Clinical guideline CG156 fertility: assessment and treatment for people with fertility problems 2017."},{"key":"2025121409055075000_11.10.e050248.16","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1472-6874-13-43","article-title":"Ultrasound mapping of pelvic endometriosis: does the location and number of lesions affect the diagnostic accuracy? A multicentre diagnostic accuracy study","volume":"13","author":"Holland","year":"2013","journal-title":"BMC Womens Health"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2021-050248","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T17:06:01Z","timestamp":1765731961000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2021-050248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":16,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,10,29]]},"published-print":{"date-parts":[[2021,10]]}},"alternative-id":["10.1136\/bmjopen-2021-050248"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2021-050248","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10]]}}}